1887

Abstract

To determine the prevalence of porcine circovirus 2 (PCV2) genotypes in the USA during 2010–2011, 5 years after widespread PCV2 vaccination, serum samples from clinically normal pigs that were PCV2 vaccinated ( = 1177), non-vaccinated ( = 378) or of unknown vaccination status ( = 120), and 100 lung samples from pigs diagnosed with PCV-associated disease (PCVAD) were tested. The presence of PCV2, PCV1, PCV1-2a and porcine parvovirus (PPV) DNA was determined by PCR. Determination of the PCV2 genotype was done by differential PCR and sequencing. The prevalence of PCV2a and PCV2b in serum samples was 7.7 % (129/1675) and 8.4 % (141/1675), respectively. PCV2a DNA was only detected in non-vaccinated pigs. For the 100 PCVAD pigs, the prevalence of PCV2a and PCV2b in lung tissues was 13.0 and 65.0 %, respectively. Partial PCV2 ORF2 sequences (9–563 nt) were obtained from 85 PCV2 DNA-positive samples (24 normal pigs and 61 PCVAD cases). Phylogenetic analysis revealed that 12.9 % (11/85) of the sequences belonged to the 2E clade and the PCV2a genotype and 87.1 % (74/85) belonged to the 1B clade and the PCV2b genotype. The alignment of putative PCV2 capsid amino acid sequences revealed possible recombination or mutation between PCV2a and PCV2b genotypes. Chimeric PCV1-2a was not detected in any of the samples and the prevalence rates of PCV1 and PPV were low. Our results suggest PCV2b is more prevalent than PCV2a in PCVAD cases and in vaccinated herds PCV2b circulation is common. The data generated in this study provide novel information on the distribution of PCV2 genotypes in vaccinated pig populations.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.039552-0
2012-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/6/1345.html?itemId=/content/journal/jgv/10.1099/vir.0.039552-0&mimeType=html&fmt=ahah

References

  1. Beach N. M., Ramamoorthy S., Opriessnig T., Wu S. Q., Meng X. J. 2010; Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs. Vaccine 29:221–232 [View Article][PubMed]
    [Google Scholar]
  2. Blanchard P., Mahé D., Cariolet R., Keranflec’h A., Baudouard M. A., Cordioli P., Albina E., Jestin A. 2003; Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 21:4565–4575 [View Article][PubMed]
    [Google Scholar]
  3. Chae J. S., Choi K. S. 2010; Genetic diversity of porcine circovirus type 2 from pigs in Republic of Korea. Res Vet Sci 88:333–338 [View Article][PubMed]
    [Google Scholar]
  4. Cheung A. K., Lager K. M., Kohutyuk O. I., Vincent A. L., Henry S. C., Baker R. B., Rowland R. R., Dunham A. G. 2007; Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Arch Virol 152:1035–1044 [View Article][PubMed]
    [Google Scholar]
  5. Cline G., Wilt V., Diaz E., Edler R. 2008; Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age. Vet Rec 163:737–740[PubMed]
    [Google Scholar]
  6. Cortey M., Olvera A., Grau-Roma L., Segalés J. 2011; Further comments on porcine circovirus type 2 (PCV2) genotype definition and nomenclature. Vet Microbiol 149:522–523 [View Article][PubMed]
    [Google Scholar]
  7. de Boisséson C., Béven V., Bigarré L., Thiéry R., Rose N., Eveno E., Madec F., Jestin A. 2004; Molecular characterization of porcine circovirus type 2 isolates from post-weaning multisystemic wasting syndrome-affected and non-affected pigs. J Gen Virol 85:293–304 [View Article][PubMed]
    [Google Scholar]
  8. Dupont K., Nielsen E. O., Baekbo P., Larsen L. E. 2008; Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Vet Microbiol 128:56–64 [View Article][PubMed]
    [Google Scholar]
  9. Fachinger V., Bischoff R., Jedidia S. B., Saalmüller A., Elbers K. 2008; The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 26:1488–1499 [View Article][PubMed]
    [Google Scholar]
  10. Fenaux M., Halbur P. G., Gill M., Toth T. E., Meng X. J. 2000; Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assay to detect and differentiate between infections with PCV-1 and PCV-2. J Clin Microbiol 38:2494–2503[PubMed]
    [Google Scholar]
  11. Fenaux M., Opriessnig T., Halbur P. G., Elvinger F., Meng X. J. 2004; A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 78:6297–6303 [View Article][PubMed]
    [Google Scholar]
  12. Firth C., Charleston M. A., Duffy S., Shapiro B., Holmes E. C. 2009; Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2. J Virol 83:12813–12821 [View Article][PubMed]
    [Google Scholar]
  13. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. 2008; Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 26:1063–1071 [View Article][PubMed]
    [Google Scholar]
  14. Gagnon C. A., Music N., Fontaine G., Tremblay D., Harel J. 2010; Emergence of a new type of porcine circovirus in swine (PCV): a type 1 and type 2 PCV recombinant. Vet Microbiol 144:18–23 [View Article][PubMed]
    [Google Scholar]
  15. Grau-Roma L., Crisci E., Sibila M., López-Soria S., Nofrarias M., Cortey M., Fraile L., Olvera A., Segalés J. 2008; A proposal on porcine circovirus type 2 (PCV2) genotype definition and their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence. Vet Microbiol 128:23–35 [View Article][PubMed]
    [Google Scholar]
  16. Guo L., Lu Y., Wei Y., Huang L., Wu H., Liu C. 2011; Porcine circovirus genotype 2a (PCV2a) and genotype 2b (PCV2b) recombinant mutants showed significantly enhanced viral replication and altered antigenicity in vitro. Virology 419:57–63 [View Article][PubMed]
    [Google Scholar]
  17. Hamel A. L., Lin L. L., Nayar G. P. 1998; Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol 72:5262–5267[PubMed]
    [Google Scholar]
  18. Harding J. C., Ellis J. A., McIntosh K. A., Krakowka S. 2010; Dual heterologous porcine circovirus genogroup 2a/2b infection induces severe disease in germ-free pigs. Vet Microbiol 145:209–219 [View Article][PubMed]
    [Google Scholar]
  19. Jantafong T., Boonsoongnern A., Poolperm P., Urairong K., Lekcharoensuk C., Lekcharoensuk P. 2011; Genetic characterization of porcine circovirus type 2 in piglets from PMWS-affected and -negative farms in Thailand. Virol J 8:88 [View Article][PubMed]
    [Google Scholar]
  20. Khaiseb S., Sydler T., Zimmermann D., Pospischil A., Sidler X., Brugnera E. 2011; Coreplication of the major genotype group members of porcine circovirus type 2 as a prerequisite to coevolution may explain the variable disease manifestations. J Virol 85:11111–11120 [View Article][PubMed]
    [Google Scholar]
  21. Kumar S., Tamura K., Jakobsen I. B., Nei M. 2001; mega2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244–1245 [View Article][PubMed]
    [Google Scholar]
  22. Larochelle R., Magar R., D’Allaire S. 2002; Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases presenting various clinical conditions. Virus Res 90:101–112 [View Article][PubMed]
    [Google Scholar]
  23. Lefebvre D. J., Costers S., Van Doorsselaere J., Misinzo G., Delputte P. L., Nauwynck H. J. 2008; Antigenic differences among porcine circovirus type 2 strains, as demonstrated by the use of monoclonal antibodies. J Gen Virol 89:177–187 [View Article][PubMed]
    [Google Scholar]
  24. Lekcharoensuk P., Morozov I., Paul P. S., Thangthumniyom N., Wajjawalku W., Meng X. J. 2004; Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J Virol 78:8135–8145 [View Article][PubMed]
    [Google Scholar]
  25. Liu J., Chen I., Kwang J. 2005; Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol 79:8262–8274 [View Article][PubMed]
    [Google Scholar]
  26. Mahé D., Blanchard P., Truong C., Arnauld C., Le Cann P., Cariolet R., Madec F., Albina E., Jestin A. 2000; Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J Gen Virol 81:1815–1824[PubMed]
    [Google Scholar]
  27. Mankertz A., Mankertz J., Wolf K., Buhk H. J. 1998; Identification of a protein essential for replication of porcine circovirus. J Gen Virol 79:381–384[PubMed]
    [Google Scholar]
  28. Martins Gomes de Castro A. M., Cortez A., Heinemann M. B., Brandão P. E., Richtzenhain L. J. 2007; Genetic diversity of Brazilian strains of porcine circovirus type 2 (PCV-2) revealed by analysis of the cap gene (ORF-2). Arch Virol 152:1435–1445 [View Article][PubMed]
    [Google Scholar]
  29. McNeilly F., McNair I., Mackle D. P., Meehan B. M., Kennedy S., Moffett D., Ellis J., Krakowka S., Allan G. M. 2001; Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2. Arch Virol 146:909–922
    [Google Scholar]
  30. Meehan B. M., McNeilly F., Todd D., Kennedy S., Jewhurst V. A., Ellis J. A., Hassard L. E., Clark E. G., Haines D. M., Allan G. M. 1998; Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol 79:2171–2179[PubMed]
    [Google Scholar]
  31. Nawagitgul P., Morozov I., Bolin S. R., Harms P. A., Sorden S. D., Paul P. S. 2000; Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol 81:2281–2287[PubMed]
    [Google Scholar]
  32. Olvera A., Cortey M., Segalés J. 2007; Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 357:175–185 [View Article][PubMed]
    [Google Scholar]
  33. Opriessnig T., McKeown N. E., Zhou E. M., Meng X. J., Halbur P. G. 2006; Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence. J Gen Virol 87:2923–2932 [View Article][PubMed]
    [Google Scholar]
  34. Opriessnig T., Meng X. J., Halbur P. G. 2007; Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 19:591–615 [View Article][PubMed]
    [Google Scholar]
  35. Opriessnig T., Madson D. M., Prickett J. R., Kuhar D., Lunney J. K., Elsener J., Halbur P. G. 2008a; Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection. Vet Microbiol 131:103–114 [View Article][PubMed]
    [Google Scholar]
  36. Opriessnig T., Ramamoorthy S., Madson D. M., Patterson A. R., Pal N., Carman S., Meng X. J., Halbur P. G. 2008b; Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. J Gen Virol 89:2482–2491 [View Article][PubMed]
    [Google Scholar]
  37. Opriessnig T., Prickett J. R., Madson D. M., Shen H. G., Juhan N. M., Pogranichniy R. R., Meng X. J., Halbur P. G. 2010; Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs. Vet Res 41:31 [View Article][PubMed]
    [Google Scholar]
  38. Opriessnig T., Gomes-Neto J. C., Hemann M., Shen H. G., Beach N. M., Huang Y., Halbur P. G., Meng X. J. 2011a; An experimental live chimeric porcine circovirus 1–2a vaccine is efficacious at decreasing porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model. Microbiol Immunol 55:863–873 [View Article][PubMed]
    [Google Scholar]
  39. Opriessnig T., Shen H. G., Pal N., Ramamoorthy S., Huang Y. W., Lager K. M., Beach N. M., Halbur P. G., Meng X. J. 2011b; A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model. Clin Vaccine Immunol 18:1261–1268 [View Article][PubMed]
    [Google Scholar]
  40. Puvanendiran S., Stone S., Yu W., Johnson C. R., Abrahante J., Jimenez L. G., Griggs T., Haley C., Wagner B., Murtaugh M. P. 2011; Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV 2 exposure and infection in swine finisher herds. Virus Res 157:92–98 [View Article][PubMed]
    [Google Scholar]
  41. Segalés J., Olvera A., Grau-Roma L., Charreyre C., Nauwynck H., Larsen L., Dupont K., McCullough K., Ellis J.other authors 2008; PCV-2 genotype definition and nomenclature. Vet Rec 162:867–868 [View Article][PubMed]
    [Google Scholar]
  42. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarías M., López-Soria S., Balasch M., Sibila M.other authors 2009; A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 27:7313–7321 [View Article][PubMed]
    [Google Scholar]
  43. Shang S. B., Jin Y. L., Jiang X. T., Zhou J. Y., Zhang X., Xing G., He J. L., Yan Y. 2009; Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Mol Immunol 46:327–334 [View Article][PubMed]
    [Google Scholar]
  44. Shen H. G., Zhou J. Y., Huang Z. Y., Guo J. Q., Xing G., He J. L., Yan Y., Gong L. Y. 2008; Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice. J Gen Virol 89:1857–1865 [View Article][PubMed]
    [Google Scholar]
  45. Shen H., Wang C., Madson D. M., Opriessnig T. 2010a; High prevalence of porcine circovirus viremia in newborn piglets in five clinically normal swine breeding herds in North America. Prev Vet Med 97:228–236 [View Article][PubMed]
    [Google Scholar]
  46. Shen H. G., Beach N. M., Huang Y. W., Halbur P. G., Meng X. J., Opriessnig T. 2010b; Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 28:5960–5966 [View Article][PubMed]
    [Google Scholar]
  47. Shen H., Thomas P. R., Ensley S. M., Kim W. I., Loynachan A. T., Halbur P. G., Opriessnig T. 2011; Vitamin E and selenium levels are within normal range in pigs diagnosed with mulberry heart disease and evidence for viral involvement in the syndrome is lacking. Transbound Emerg Dis 58:483–491 [View Article][PubMed]
    [Google Scholar]
  48. Timmusk S., Wallgren P., Brunborg I. M., Wikström F. H., Allan G., Meehan B., McMenamy M., McNeilly F., Fuxler L.other authors 2008; Phylogenetic analysis of porcine circovirus type 2 (PCV2) pre- and post-epizootic postweaning multisystemic wasting syndrome (PMWS). Virus Genes 36:509–520 [View Article][PubMed]
    [Google Scholar]
  49. Tischer I., Rasch R., Tochtermann G. 1974; Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl Bakteriol [Orig A] 226:153–167[PubMed]
    [Google Scholar]
  50. Tischer I., Gelderblom H., Vettermann W., Koch M. A. 1982; A very small porcine virus with circular single-stranded DNA. Nature 295:64–66 [View Article][PubMed]
    [Google Scholar]
  51. Tischer I., Mields W., Wolff D., Vagt M., Griem W. 1986; Studies on epidemiology and pathogenicity of porcine circovirus. Arch Virol 91:271–276 [View Article][PubMed]
    [Google Scholar]
  52. Truong C., Mahe D., Blanchard P., Le Dimna M., Madec F., Jestin A., Albina E. 2001; Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch Virol 146:1197–1211 [View Article][PubMed]
    [Google Scholar]
  53. Wang F., Guo X., Ge X., Wang Z., Chen Y., Cha Z., Yang H. 2009; Genetic variation analysis of Chinese strains of porcine circovirus type 2. Virus Res 145:151–156 [View Article][PubMed]
    [Google Scholar]
  54. Wellenberg G. J., Pesch S., Berndsen F. W., Steverink P. J., Hunneman W., Van der Vorst T. J., Peperkamp N. H., Ohlinger V. F., Schippers R.other authors 2000; Isolation and characterization of porcine circovirus type 2 from pigs showing signs of post-weaning multisystemic wasting syndrome in The Netherlands. Vet Q 22:167–172 [View Article][PubMed]
    [Google Scholar]
  55. Wen L., Guo X., Yang H. 2005; Genotyping of porcine circovirus type 2 from a variety of clinical conditions in China. Vet Microbiol 110:141–146 [View Article][PubMed]
    [Google Scholar]
  56. Zhou J. Y., Sheng S. B., Gong H., Chen Q. X., Wu J. X., Shen H. G., Chen T. F., Guo J. Q. 2005; In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. J Biotechnol 118:201–211 [View Article][PubMed]
    [Google Scholar]
  57. Zhou J. Y., Chen Q. X., Ye J. X., Shen H. G., Chen T. F., Shang S. B. 2006; Serological investigation and genomic characterization of PCV2 isolates from different geographic regions of Zhejiang province in China. Vet Res Commun 30:205–220 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.039552-0
Loading
/content/journal/jgv/10.1099/vir.0.039552-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error